Gender | |
---|---|
Male | 9 |
Female | 3 |
Age | 61 (range 49–70) |
Disease site | |
Oropharynx | 8 |
Oral | 1 |
Nasopharynx | 2 |
Larynx | 1 |
T Stage | |
2 | 5 |
3 | 5 |
4 | 2 |
Node stage | |
0 | 2 |
1 | 3 |
2 | 7 |
Treatment | |
Chemoradiotherapy | 9 |
Surgery and radiotherapy +/− chemotherapy | 3 |
Time post-treatment (months) | Median 5 range 1–60 |
MDADI pre to post CB-EST | |
Decreased (4–19 points) | 3 |
Similar (0–4 points) | 3 |
Increased (5–36 points) | 6 |